Literature DB >> 2496585

Plasma aspirin esterase: the influence of old age and frailty.

F M Williams1, H Wynne, K W Woodhouse, M D Rawlins.   

Abstract

Plasma aspirin esterase activity, expressed as nmol salicylate formed/ml plasma/min, was found to be similar in a group of healthy elderly adults, a group of young adults and a group of frail young adults, but was lower in a sample of frail elderly subjects. This was associated with reduced plasma albumin levels in healthy elderly subjects compared with young subjects and levels were lower still in the frail elderly group. Plasma cholinesterase also showed a trend towards reduced activity in the frail elderly subjects. As plasma aspirin esterase activity may influence the amount of circulating aspirin, these changes may have implications for the use of aspirin in frail elderly people.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496585     DOI: 10.1093/ageing/18.1.39

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  23 in total

Review 1.  Drug metabolism and ageing.

Authors:  M T Kinirons; M S O'Mahony
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  The 'apparent clearance' of free phenytoin in elderly vs. younger adults.

Authors:  Daniel F B Wright; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 4.  Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 5.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

Review 6.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  M T Kinirons; P Crome
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

7.  Safe and Effective Prescribing for the Elderly: A look at factors linked with adverse drug reactions.

Authors:  C Macarthur; K Rockwood
Journal:  Can Fam Physician       Date:  1992-01       Impact factor: 3.275

Review 8.  Geriatric conditions and the risk of adverse drug reactions in older adults: a review.

Authors:  Fabrizia Lattanzio; Francesco Landi; Silvia Bustacchini; Angela Marie Abbatecola; Francesco Corica; Luigi Pranno; Andrea Corsonello
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

Review 9.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

10.  Serum cholesterol concentration associated with aspirin esterase activity in older people: preliminary data.

Authors:  Kazuhiko Kotani; Russell Caccavello; Ricardo Hermo; Toshiyuki Yamada; Nobuyuki Taniguchi; Alejandro Gugliucci
Journal:  Int J Med Sci       Date:  2010-05-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.